|
apoptosis - drug effects |
7 |
|
autophagy - drug effects |
6 |
|
cholestenones - pharmacology |
6 |
|
endoplasmic reticulum - drug effects - pathology |
6 |
|
sarcoplasmic reticulum calcium-transporting atpases - antagonists and inhibitors |
6 |
|
copper |
4 |
|
asymmetric reduction |
3 |
|
cyclization |
3 |
|
cycloaddition |
3 |
|
domino reactions |
3 |
|
feedback |
3 |
|
motivation |
3 |
|
rhodium |
3 |
|
student learning |
3 |
|
sulfur heterocycles |
3 |
|
teaching |
3 |
|
total synthesis |
3 |
|
transition metal catalysis |
3 |
|
aldol reaction |
2 |
|
alkynes |
2 |
|
allylic compounds |
2 |
|
angiogenesis inhibitors |
2 |
|
animals |
2 |
|
anti-infective agents |
2 |
|
antineoplastic agents - chemistry - pharmacology - therapeutic use |
2 |
|
asymmetric catalysis |
2 |
|
asymmetric synthesis |
2 |
|
aza-michael reactions |
2 |
|
bicyclic compounds |
2 |
|
binding sites |
2 |
|
binding, competitive - drug effects |
2 |
|
biological products - chemical synthesis - chemistry - isolation and purification - pharmacology |
2 |
|
blotting, western |
2 |
|
brook rearrangement |
2 |
|
brønsted acid and base |
2 |
|
carbenes |
2 |
|
carbenoids |
2 |
|
cascade reaction |
2 |
|
cascade reactions |
2 |
|
catalysis |
2 |
|
cell cycle proteins - metabolism |
2 |
|
cell division - drug effects |
2 |
|
cell line |
2 |
|
cell line, tumor |
2 |
|
cell survival - drug effects |
2 |
|
colchicine - pharmacology |
2 |
|
cycloadditions |
2 |
|
cycloheptanoids |
2 |
|
deactivation |
2 |
|
diazo compounds |
2 |
|
diterpenes - chemical synthesis - chemistry |
2 |
|
diterpenes - chemical synthesis - chemistry - isolation and purification - pharmacology |
2 |
|
diterpenes - chemistry - pharmacology - therapeutic use |
2 |
|
domino reaction |
2 |
|
dose-response relationship, drug |
2 |
|
drug resistance, multiple - drug effects |
2 |
|
drug resistance, neoplasm - drug effects |
2 |
|
drugs, chinese herbal |
2 |
|
drugs, chinese herbal - chemical synthesis - chemistry - isolation and purification - pharmacology |
2 |
|
enantioselective catalysis |
2 |
|
enantioselectivity |
2 |
|
epoxides |
2 |
|
furan |
2 |
|
g2 phase - drug effects |
2 |
|
hela cells |
2 |
|
heterocycles |
2 |
|
heterocycles(4 + 3) cycloaddition |
2 |
|
humans |
2 |
|
hydrostannation |
2 |
|
indicol |
2 |
|
intramolecular |
2 |
|
lewis acid |
2 |
|
liver neoplasms - drug therapy - metabolism - pathology |
2 |
|
male |
2 |
|
methane - analogs and derivatives - chemistry |
2 |
|
mice |
2 |
|
mice, inbred balb c |
2 |
|
mice, nude |
2 |
|
microscopy, fluorescence |
2 |
|
microtubules - metabolism |
2 |
|
molecular structure |
2 |
|
natural products |
2 |
|
oxabicyclic |
2 |
|
peroxides |
2 |
|
phenylenediamine |
2 |
|
piperidine |
2 |
|
pseudolarolides |
2 |
|
reduction |
2 |
|
regioselectivity |
2 |
|
ring opening |
2 |
|
ruthenium - chemistry |
2 |
|
silyllithium reagents |
2 |
|
stereoselectivity |
2 |
|
synthetic methods |
2 |
|
time factors |
2 |
|
treatment outcome |
2 |
|
triterpenes |
2 |
|
tubulin - metabolism |
2 |
|
vinylstannanes |
2 |
|
water-effect |
2 |
|
x-ray diffraction |
2 |
|
xenograft model antitumor assays - methods |
2 |
|
ylides |
2 |
|
(3+2) cycloadditions epoxides |
1 |
|
(4+3) cycloadditions |
1 |
|
[4+3] cycloaddition |
1 |
|
aldol reactions |
1 |
|
alkaloid |
1 |
|
alkaloids |
1 |
|
alkenes - chemistry |
1 |
|
allenes |
1 |
|
anti-bacterial agents - chemical synthesis |
1 |
|
antitumor agents |
1 |
|
apoptosis |
1 |
|
apoptosis-resistant |
1 |
|
arenes |
1 |
|
arsine |
1 |
|
asia |
1 |
|
autophagy |
1 |
|
aza-bridge |
1 |
|
aziridines |
1 |
|
biological products |
1 |
|
carbonyl ylide |
1 |
|
carbonyl ylides |
1 |
|
catalyst |
1 |
|
chemistry |
1 |
|
chemistry, organic |
1 |
|
claisen rearrangements |
1 |
|
colon cancer |
1 |
|
congresses as topic |
1 |
|
conjugate reduction |
1 |
|
controlled study |
1 |
|
cope rearrangement |
1 |
|
copper and compounds |
1 |
|
copper conjugate reductions |
1 |
|
copper hydride |
1 |
|
copper hydrides |
1 |
|
cortistatins |
1 |
|
cross linking |
1 |
|
cross-coupling |
1 |
|
cycloaddition reaction |
1 |
|
cycloheptanes |
1 |
|
cycloisomerization |
1 |
|
cyclopropanation |
1 |
|
dearomatization |
1 |
|
dearomatization’ |
1 |
|
density functional calculations |
1 |
|
density-functional calculations |
1 |
|
desulfurization |
1 |
|
dft calculations |
1 |
|
diazoketones |
1 |
|
dipolar cycloaddition |
1 |
|
diterpenes - chemical synthesis |
1 |
|
enantioselective |
1 |
|
epoxy compounds - chemistry |
1 |
|
epoxy enolsilanes |
1 |
|
fluorinated drugs |
1 |
|
fty720 |
1 |
|
growth arrest |
1 |
|
heterocyclic compounds with 4 or more rings - chemical synthesis - chemistry |
1 |
|
hydride |
1 |
|
hydrogen bonding |
1 |
|
immunosuppressive agent |
1 |
|
indolizine |
1 |
|
international cooperation |
1 |
|
isoquinolines - chemical synthesis - chemistry |
1 |
|
ketones - chemistry |
1 |
|
kinetic resolution, asymmetric catalysis, copper, aziridines, azirines |
1 |
|
macrocycles |
1 |
|
meso 8 oxabicyclo( 3.2.1 )octen 3 one |
1 |
|
methylenecyclopropane |
1 |
|
mtor |
1 |
|
nag-1 |
1 |
|
natural product synthesis |
1 |
|
nickel |
1 |
|
nitro-aldol reactions |
1 |
|
nitroalkenes |
1 |
|
organic chemistry |
1 |
|
organosilanes |
1 |
|
oxyallylic cations |
1 |
|
palladium |
1 |
|
phosphorous ligands |
1 |
|
phosphorus |
1 |
|
pkc-α |
1 |
|
polycyclic |
1 |
|
polycyclic compounds - chemical synthesis - chemistry |
1 |
|
polymer support |
1 |
|
protecting groups |
1 |
|
pseudolaric acid |
1 |
|
pseudolaric acid b |
1 |
|
pyrroles |
1 |
|
quinoline |
1 |
|
reaction mechanisms |
1 |
|
reductions |
1 |
|
reductive aldol |
1 |
|
research |
1 |
|
rhodium carbene |
1 |
|
silanes |
1 |
|
silanes - chemistry |
1 |
|
silicon and compounds |
1 |
|
societies, scientific - organization & administration |
1 |
|
sonogashira coupling |
1 |
|
spirocycles |
1 |
|
stannanes |
1 |
|
stereocontrol |
1 |
|
stereoisomerism |
1 |
|
stryker' s reagents |
1 |
|
stryker's reagent |
1 |
|
substrate specificity |
1 |
|
tandem reactions |
1 |
|
tetrandrine |
1 |
|
thiophenes |
1 |
|
transannular |
1 |
|
triptolide |
1 |
|
tropanes |
1 |
|
wittig reaction |
1 |
|
α,β-unsaturated compounds |
1 |
